These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16372253)

  • 1. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal epithelial neoplasms: diagnostic applications of gene expression profiling.
    Young AN; Master VA; Paner GP; Wang MD; Amin MB
    Adv Anat Pathol; 2008 Jan; 15(1):28-38. PubMed ID: 18156810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in the molecular classification of renal neoplasms.
    Young AN; Master VA; Amin MB
    ScientificWorldJournal; 2006 Dec; 6():2505-18. PubMed ID: 17619725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate molecular classification of kidney cancer subtypes using microRNA signature.
    Youssef YM; White NM; Grigull J; Krizova A; Samy C; Mejia-Guerrero S; Evans A; Yousef GM
    Eur Urol; 2011 May; 59(5):721-30. PubMed ID: 21272993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of gene expression analysis of renal cell carcinoma.
    Leppert JT; Pantuck AJ
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.
    Furge KA; Lucas KA; Takahashi M; Sugimura J; Kort EJ; Kanayama HO; Kagawa S; Hoekstra P; Curry J; Yang XJ; Teh BT
    Cancer Res; 2004 Jun; 64(12):4117-21. PubMed ID: 15205321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of renal neoplasms based on molecular signatures.
    Yang XJ; Sugimura J; Schafernak KT; Tretiakova MS; Han M; Vogelzang NJ; Furge K; Teh BT
    J Urol; 2006 Jun; 175(6):2302-6. PubMed ID: 16697863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.
    Young AN; Amin MB; Moreno CS; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS
    Am J Pathol; 2001 May; 158(5):1639-51. PubMed ID: 11337362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the molecular signatures of renal cell carcinoma by gene expression profiling.
    Takahashi M; Teh BT; Kanayama HO
    J Med Invest; 2006 Feb; 53(1-2):9-19. PubMed ID: 16537991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of renal cell carcinoma: an update.
    Lopez-Beltran A; Cheng L; Vidal A; Scarpelli M; Kirkali Z; Blanca A; Montironi R
    Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):61-76. PubMed ID: 23700715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal cell carcinoma diagnosis and prognosis within the context of the WHO classification 2016].
    Zimpfer A; Glass Ä; Zettl H; Maruschke M; Hakenberg OW; Erbersdobler A
    Urologe A; 2019 Sep; 58(9):1057-1065. PubMed ID: 31093717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
    Gonzalgo ML; Yegnasubramanian S; Yan G; Rogers CG; Nicol TL; Nelson WG; Pavlovich CP
    Clin Cancer Res; 2004 Nov; 10(21):7276-83. PubMed ID: 15534102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.